Frankfurt
05.01.26 | 08:18
2,860 Euro
+0,70 % +0,020
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05:19 | AVITA MEDICAL INC.: Notification of cessation of securities - AVH | 1 | ASX | ||
| 18.12.25 | AVITA MEDICAL INC.: AVITA to Present at 2026 JP Morgan Healthcare Conference | 5 | ASX | ||
| 11.12.25 | AVITA MEDICAL INC.: Notification regarding unquoted securities - AVH | - | ASX | ||
| AVITA MEDICAL Aktie jetzt für 0€ handeln | |||||
| 11.12.25 | AVITA MEDICAL INC.: Notification of cessation of securities - AVH | - | ASX | ||
| 07.12.25 | AVITA MEDICAL INC.: Notice under section 708A(5)(e) of the Corporations Act | - | ASX | ||
| 07.12.25 | AVITA MEDICAL INC.: Notification regarding unquoted securities - AVH | - | ASX | ||
| 04.12.25 | AVITA MEDICAL INC.: Statement of CDIs on issue - AVH | 1 | ASX | ||
| 01.12.25 | AVITA MEDICAL INC.: Notification of cessation of securities - AVH | - | ASX | ||
| 24.11.25 | AVITA MEDICAL INC.: AVITA to Present at the Piper Sandler Healthcare Conference | - | ASX | ||
| 20.11.25 | BTIG upgrades Avita Medical stock rating to Neutral from Sell | 2 | Investing.com | ||
| 11.11.25 | AVITA MEDICAL INC.: Notification regarding unquoted securities - AVH | - | ASX | ||
| 11.11.25 | XFRA NEW INSTRUMENTS AVAILABLE ON 11.11.2025 | 510 | Xetra Newsboard | The following instruments on XETRA do have their first trading 11.11.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 11.11.2025
Aktien
1 AU0000165375 Clarity Pharmaceuticals... ► Artikel lesen | |
| 10.11.25 | AVITA MEDICAL INC.: AVITA Medical Q3 investor presentation | 13 | ASX | ||
| 09.11.25 | AVITA MEDICAL INC.: AVITA Medical to Host Investor Webinar Briefing | 12 | ASX | ||
| 07.11.25 | BTIG bekräftigt "Sell"-Rating für Avita Medical angesichts von Erstattungsproblemen | 11 | Investing.com Deutsch | ||
| 07.11.25 | BTIG reiterates Sell rating on Avita Medical stock amid reimbursement woes | 3 | Investing.com | ||
| 07.11.25 | Avita Medical signals revenue recovery with $70M-$74M 2025 outlook following reimbursement clarity | 2 | Seeking Alpha | ||
| 06.11.25 | AVITA MEDICAL INC.: AVITA Q3 2025 Presentation | - | ASX | ||
| 06.11.25 | AVITA MEDICAL INC.: AVITA 10Q Quarterly Report for Q3 2025 | 1 | ASX | ||
| 06.11.25 | AVITA MEDICAL INC.: AVITA Q3 2025 Press Release | - | ASX |
1 2 3 4 5 Weiter >>
100 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 14,830 | -2,82 % | Eckert&Ziegler-Aktie sorgt für Aufsehen: Analysten sprechen von erhöhter Dynamik - unbedingt hinschauen! | ||
| UNITEDHEALTH | 288,20 | +0,37 % | ROUNDUP/Aktien New York: Kaum verändert am vorletzten Handelstag des Jahres | NEW YORK (dpa-AFX) - Bei den wichtigsten US-Aktienindizes hat sich am Dienstag am vorletzten Handelstag des Jahres wenig getan. Der Dow Jones Industrial sank im frühen Handel um 0,08 Prozent auf 48.423... ► Artikel lesen | |
| ROKU | 95,37 | +2,80 % | Citizens reiterates Market Outperform rating on Roku stock at $145 target | ||
| MCKESSON | 704,80 | +0,28 % | McKesson (MCK) Gets Higher Target at Deutsche Bank Despite Planned Spin-Off | ||
| SENSEONICS | 4,840 | +7,56 % | Senseonics Holdings, Inc. - 8-K, Current Report | ||
| ELEKTA | 5,270 | +0,10 % | Elekta AB: Second quarter, August-October 2025/26 | Second quarterIn constant exchange rates, net sales increased by 1 percent mainly driven by Europe. Reported sales in SEK decreased by 6 percent amounting to SEK 4,070 M (4,341).The book-to-bill ratio... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 38,400 | 0,00 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| GENEDX | 132,30 | 0,00 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PROGYNY | 25,740 | 0,00 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,225 | 0,00 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 30,760 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,440 | -1,07 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers vor Zahlen zum ersten Geschäftsquartal auf "Buy" mit einem Kursziel von 60 Euro belassen. Der Medizintechnikkonzern... ► Artikel lesen | |
| BETA BIONICS | 29,250 | -4,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| ADAPTHEALTH | 9,670 | 0,00 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| PRIVIA HEALTH GROUP | 23,460 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen |
AVITA MEDICAL INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 2,860 Euro und damit +0,70 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AVITA MEDICAL INC finden Sie auf Wallstreet Online.